Vimarsana
Biggest News Aggregation in the World

Page 9 - Data Science Centre News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Data Science Centre. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Data Science Centre Today - Breaking & Trending Today

Very small blood clot risk after first AstraZeneca Covid shot — UK studies - Vimarsana News

Very small blood clot risk after first AstraZeneca Covid shot — UK studies

A large study into rare blood clots linked with AstraZeneca's (AZN.L) Covid-19 vaccine found between just one and three cases per million, and only after the

Slightly Greater Risk of Blood Clots with AstraZeneca COVID Vaccine - Vimarsana News

Slightly Greater Risk of Blood Clots with AstraZeneca COVID Vaccine

Two large UK studies find the risk of intracranial thrombosis is slightly increased in some people after the AstraZeneca COVID-19 vaccine.

Very small blood clot risk after first AstraZeneca COVID shot - Vimarsana News

Very small blood clot risk after first AstraZeneca COVID shot

A large study into rare blood clots linked with AstraZeneca's COVID-19 vaccine found between just one and three cases per million, and only after the first dose, shedding fresh light on the...

Ground News - Very small blood clot risk after first AstraZeneca COVID shot - Vimarsana News

Ground News - Very small blood clot risk after first AstraZeneca COVID shot

By Pushkala Aripaka - A large study into rare blood clots linked with AstraZeneca's COVID-19 vaccine found between just one and three cases per million, and only after the first dose, shedding fresh light on the side-effects from the shot. Researchers have sought to analyse any link between COVID-19 vaccines and rare blood clots in the brain, arteries or veins - sometimes accompanied

Association of COVID-19 vaccines ChAdOx1 and BNT162b2 with major venous, arterial, or thrombocytopenic events: A population-based cohort study of 46 million adults in England - Vimarsana News

Association of COVID-19 vaccines ChAdOx1 and BNT162b2 with major venous, arterial, or thrombocytopenic events: A population-based cohort study of 46 million adults in England

In a population-based cohort study, William Whiteley and colleagues investigate the association of COVID-19 vaccines ChAdOx1 and BNT162b2 with major venous, arterial, or thrombocytopenic events in England.

Source: plos.org